Yun-Zi Wu1, Bin Li, Tao Wang, Shuang-Jia Wang, Yan-Ming Zhou. 1. Department of Hepato-Biliary-Pancreato-Vascular Surgery, the First Affiliated Hospital of Xiamen University, Xiamen 361003, Fujian Province, China.
Abstract
AIM: To evaluate the comparative therapeutic efficacy of radiofrequency ablation (RFA) and hepatic resection (HR) for solitary colorectal liver metastases (CLM). METHODS: A literature search was performed to identify comparative studies reporting outcomes for both RFA and HR for solitary CLM. Pooled odds ratios (OR) with 95% confidence intervals (95% CI) were calculated using either the fixed effects model or random effects model. RESULTS: Seven nonrandomized controlled trials studies were included in this analysis. These studies included a total of 847 patients: 273 treated with RFA and 574 treated with HR. The 5 years overall survival rates in the HR group were significantly better than those in the RFA group (OR: 0.41, 95% CI: 0.22-0.90, P = 0.008). RFA had a higher rate of local intrahepatic recurrence compared to HR (OR: 4.89, 95% CI: 1.73-13.87, P = 0.003). No differences were found between the two groups with respect to postoperative morbidity and mortality. CONCLUSION: HR was superior to RFA in the treatment of patients with solitary CLM. However, the findings have to be carefully interpreted due to the lower level of evidence.
AIM: To evaluate the comparative therapeutic efficacy of radiofrequency ablation (RFA) and hepatic resection (HR) for solitary colorectal liver metastases (CLM). METHODS: A literature search was performed to identify comparative studies reporting outcomes for both RFA and HR for solitary CLM. Pooled odds ratios (OR) with 95% confidence intervals (95% CI) were calculated using either the fixed effects model or random effects model. RESULTS: Seven nonrandomized controlled trials studies were included in this analysis. These studies included a total of 847 patients: 273 treated with RFA and 574 treated with HR. The 5 years overall survival rates in the HR group were significantly better than those in the RFA group (OR: 0.41, 95% CI: 0.22-0.90, P = 0.008). RFA had a higher rate of local intrahepatic recurrence compared to HR (OR: 4.89, 95% CI: 1.73-13.87, P = 0.003). No differences were found between the two groups with respect to postoperative morbidity and mortality. CONCLUSION: HR was superior to RFA in the treatment of patients with solitary CLM. However, the findings have to be carefully interpreted due to the lower level of evidence.
Authors: Thomas A Aloia; Jean-Nicolas Vauthey; Evelyne M Loyer; Dario Ribero; Timothy M Pawlik; Steven H Wei; Steven A Curley; Daria Zorzi; Eddie K Abdalla Journal: Arch Surg Date: 2006-05
Authors: Eren Berber; Michael Tsinberg; Gurkan Tellioglu; Conrad H Simpfendorfer; Allan E Siperstein Journal: J Gastrointest Surg Date: 2008-08-08 Impact factor: 3.452
Authors: In Ja Park; Hee Cheol Kim; Chang Sik Yu; Pyo Nyun Kim; Hyung Jin Won; Jin Cheon Kim Journal: Ann Surg Oncol Date: 2007-09-20 Impact factor: 5.344
Authors: R R White; I Avital; C T Sofocleous; K T Brown; L A Brody; A Covey; G I Getrajdman; W R Jarnagin; R P Dematteo; Y Fong; L H Blumgart; M D'Angelica Journal: J Gastrointest Surg Date: 2007-03 Impact factor: 3.267
Authors: Il Soo Chang; Young Jun Kim; Sang Woo Park; Hee Sun Park; Hae Jeong Jeon; Seong-Hwan Chang; Dae-Yong Hwang Journal: Ann Surg Treat Res Date: 2014-06-24 Impact factor: 1.859
Authors: Woon-Won Kim; Ki Hoon Kim; Sam Hee Kim; Jin Soo Kim; Sung Jin Park; Kwang Hee Kim; Chang Su Choi; Young Kil Choi Journal: Indian J Surg Date: 2015-03-24 Impact factor: 0.656
Authors: Karin Nielsen; Aukje A J M van Tilborg; Martijn R Meijerink; Matessa O Macintosh; Babs M Zonderhuis; Elly S M de Lange; Emile F I Comans; Sybren Meijer; M Petrousjka van den Tol Journal: World J Surg Date: 2013-06 Impact factor: 3.352